SCM
ABEO icon

Sterling Capital Management’s Abeona Therapeutics ABEO Stock Holding History

Sterling Capital Management’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.55K Sell
346
-81
-19% -$405 ﹤0.01% 3036
2025
Q4 		$2.25K Buy
427
+169
+66% +$851 ﹤0.01% 3051
2025
Q3 		$1.36K Buy
258
+96
+59% +$609 ﹤0.01% 3037
2025
Q2 		$920 Buy
+162
New +$922 ﹤0.01% 3075

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Sterling Capital Management's ABEO Position: Q1 2026 in Review

Sterling Capital Management reduced its Abeona Therapeutics (ABEO) stake by 19% in Q1 2026, selling an estimated $405 and leaving 346 shares worth $1.55K. The position accounts for ﹤0.01% of the portfolio, ranked #3036.

Sterling Capital Management first reported a position in ABEO in Q2 2025 and has held it in 4 quarters since. The position peaked at $2.25K in Q4 2025. 108 funds tracked by Wall St. Rank hold ABEO as of Q1 2026.

  • Sterling Capital Management held 346 shares of Abeona Therapeutics worth $1.55K as of Q1 2026.
  • Sterling Capital Management sold 81 Abeona Therapeutics shares in Q1 2026, an estimated $405.
  • Abeona Therapeutics made up ﹤0.01% of Sterling Capital Management's portfolio in Q1 2026, its #3036 holding.
  • Sterling Capital Management first reported a position in Abeona Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • Sterling Capital Management's Abeona Therapeutics position peaked at $2.25K in Q4 2025.
  • 108 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q1 2026.

Based on Sterling Capital Management's 13F filing for Q1 2026, filed 22 Apr 2026.